The market seedling era has arrived
China's veterinary biological products started in 1918, the Qingdao Institute of Commodity Inspection, and the Beiping Central Epidemic Prevention Office established in 1919. Since the promulgation of the first "Veterinary Biopharmaceutical Manufacturing and Inspection Regulations" in 1952, China's animal vaccine has experienced many stages from extensive to standardized rapid development, and has now developed into a high-growth industry covering a variety of animal diseases.
Chart 1: The development of China's animal vaccine industry
Source: Prospective Industry Research Institute
The international animal vaccine market has exceeded 10 billion US dollars
Driven by a series of factors such as the increase in global animal feed demand, feeding methods, epidemic diseases and product innovation, the market demand for international veterinary vaccines has increased continuously in recent years, and the market scale has also increased year by year. In 2011, the international veterinary vaccine market was approximately $6.4 billion; in 2016, this figure reached $10.6 billion.
Chart 2: The size and growth of the international veterinary vaccine market in 2011-2017 (unit: billion US dollars, %)
Source: Prospective Industry Research Institute
The frequent outbreak of global animal epidemics, increased support from governments, increased requirements for animal food hygiene and safety, and rapid growth of the pet market are the main factors contributing to the rapid growth of the global veterinary vaccine market.
Domestic animal vaccine market scale exceeds 20 billion yuan
In recent years, due to the increased investment in epidemic prevention by the state, a mandatory immunization system has been implemented to promote the rapid growth of the veterinary vaccine market in China. Before 2004, the animal disease that was included in the national mandatory immunization area was only foot-and-mouth disease. Since 2004, major animal diseases such as highly pathogenic avian influenza, highly pathogenic swine blue ear disease, swine fever, and small ruminant plague have gradually been included in the national compulsory immunization, which has greatly promoted the market demand for related vaccine products. . Especially in 2007, high pathogenic pig blue ear disease and swine fever were included in the national mandatory immunization range, and the domestic veterinary vaccine market grew by a large margin. Although in 2017, the state is no longer mandatory for high-pathogenic swine blue ear disease and swine fever, the animal vaccine market will continue to be standardized and regularized in China for animal husbandry and food safety. Faced with good development opportunities.
Judging from the scale of China's veterinary vaccine market, the market size of China's veterinary vaccine in 2011 was only 9.8 billion yuan. By 2016, the market size of the industry was about 20.3 billion yuan.
China Extract Powder For Use As Dietary Supplement Extract Powder, Extract Powder Manufacturer
Shaanxi Kang New Pharmaceutical co., Ltd. , https://www.kangnewpharmas.com